Dudediligence.

VolitionRx Limited

VNRXAMEX · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price

From the filings

Figures

Revenue
$2.5Mlast 12 months
Net income
−$25.6Mlast 12 months
Operating cash flow
−$20.7Mlast 12 months
Cash and equivalents
$2.8Mat the last balance sheet
Total debt
$7.1Mat the last balance sheet
Shares outstanding
12.0M shareson issue
Every year and quarter →